Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development

Biology of the Neonate

Volumn 82, Issue 3, 2002, Pages 207-216

  McLaughlin, Patricia J ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cardiac hypertrophy; DNA; Endogenous opioids; Heart morphogenesis; Naltrexone; Protein concentration; Receptors; RNA

Indexed keywords

DNA; NALTREXONE; NUCLEIC ACID; OPIATE ANTAGONIST;

ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HEART DEVELOPMENT; MALE; MORPHOMETRICS; NONHUMAN; POSTNATAL DEVELOPMENT; PREGNANCY; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PROTEIN CONTENT; RAT; RAT STRAIN;

AGING; ANIMALS; BODY WEIGHT; DNA; FEMALE; GESTATIONAL AGE; HEART; LITTER SIZE; MALE; MYOCARDIUM; NALTREXONE; NARCOTIC ANTAGONISTS; OPIOID PEPTIDES; ORGAN SIZE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RNA;

ANIMALIA;

EID: 0036428311     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000063611     Document Type: Article

References (47)

1. Akil H, Watson SJ, Young E, Lewis ME, Katchaturian H, Walter MJ: Endogenous opioids: Biology and function. Annu Rev Neurosci 1984;7:223-255.
2. Barg J, Belcheva M, McHale R, Levey R, Vogel Z, Coscia CJ: β-Endorphin is a potent inhibitor of thymidine incorporation into DNA via μ-and κ-opioid receptors in fetal rat brain cell aggregates in culture. J Neurochem 1996;60:765-767.
3. Bartolome JV, Bartolome MB, Lorber BA, Dileo SJ, Schanberg SM: Effects of central administration of beta-endorphin on brain and liver DNA-synthesis in preweaning rats. Neuroscience 1991;40:289-294.
4. Blebea J, Mazo JE, Kihara TK, McLaughlin PJ, Atnip RG, Zagon IS: Differential effects of vascular endothelial growth factors on arterial and venous angiogenesis. J Vasc Surg 2001, in press.
5. Leng G, Mansfield S, Bicknell RJ, Dean ADP, Ingram CD, Marsh MIC, Yates JO, Dyer RG: Central opioids: A possible role in parturition? J Endocrinol 1985;106:219-224.
6. McLaughlin PJ: Opioid antagonist modulation of rat heart development. Life Sci 1994;54:1423-1431.
7. 5]-enkephalin. Am J Physiol 1996;271:R122-R129.
8. McLaughlin PJ, Wu Y: Opioid gene expression in the developing and adult rat heart. Dev Dyn 1998;211:153-163.
9. Najam N, Panksepp J: Effect of chronic neonatal morphine and naloxone on sensorimotor and social development of young rats. Pharmacol Biochem Behav 1989;33:539-544.
10. Nieder GL, Corder CN: Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice. J Reprod Fertil 1982;65:341-346.
11. Zagon IS, McLaughlin PJ: Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res 1991;542:318-323.
12. Zagon IS, Wu Y, McLaughlin PJ: Opioid growth factor and organ development in rat and human embryos. Brain Res 1999a;839:313-322.
13. Zagon IS, McLaughlin PS: Opioid growth factor receptor in the developing nervous system; in Zagon IS, McLaughlin PJ (eds): Receptors in the Developing Nervous System. London, Chapman & Hall, 1993, vol 1: Growth Factors and Hormones, pp 39-62.
14. Zagon IS, Verderame MF, McLaughlin PJ: The biology of the opioid growth factor receptor (OGFr). Brain Res Brain Res Rev 2002;38:351-376.
15. Bisignani GJ, McLaughlin PJ, Ordille SD, Jarowenko MJ, Zagon IS: Human renal cell proliferation in tissue culture is tonically inhibited by opioid growth factor. J Urol 1999;162:2186-2191.
16. Zagon IS, Smith JP, McLaughlin PJ: Human pancreatic cancer cell proliferation in tissue culture is tonically inhibited by opioid growth factor. Int J Oncol 1999;14:577-584.
17. McLaughlin PJ, Levin RJ, Zagon IS: Regulation of human head and neck squamous cell carcinoma growth in tissue culture by opioid growth factor. Int J Oncol 1999;14:991-998.
18. 5]-enkephalin. Brain Res 1999;849:147-154.
19. Zagon IS, Verderame MF, Allen SS, McLaughlin PJ: Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans. Brain Res 2000;56:75-83.
20. Zagon IS, Verderame MF, Zimmer WE, McLaughlin PJ: Molecular characterization and distribution of the opioid growth factor receptor (OGFr) in mouse. Mol Brain Res 2000;84:106-114.
21. Cohen E, Keshet G, Shavit Y, Weinstock M: Prenatal naltrexone facilitates male sexual behavior in the rat. Pharmacol Biochem Behav 1996;54:183-189.
22. Shepanek NA, Smith RF, Anderson LA, Medici CN: Behavioral and developmental changes associated with prenatal opiate receptor blockade. Pharmacol Biochem Behav 1995;50:313-319.
23. McLaughlin PJ, Tobias SW, Lang CM, Zagon IS: Chronic exposure to the opioid antagonist naltrexone during pregnancy: Maternal and offspring effects. Physiol Behav 1997;16:501-508.
24. McLaughlin PJ, Tobias SW, Lang CM, Zagon IS: Opioid receptor blockade during prenatal life modifies postnatal behavioral development. Pharmacol Biochem Behav 1997;58:1075-1082.
25. Zagon IS, McLaughlin PJ: Increased brain size and cellular content in infant rats treated with opiate antagonist. Science 1983;21:1179-1180.
26. Zagon IS, McLaughlin PJ: Naltrexone modulates growth in infant rats. Life Sci 1983;33:2449-2454.
27. Zagon IS, McLaughlin PJ: Naltrexone modulates body and brain development in rats: A role for endogenous opioid systems in growth. Life Sci 1984;35:2057-2064.
28. Zagon IS, McLaughlin PJ: Opioid antagonist-induced regulation of organ development. Physiol Behav 1985;34:507-511.
29. Zagon IS, McLaughlin PJ: Naltrexone's influence on neurobehavioral development. Pharmacol Biochem Behav 1985;22:441-448.
30. Zagon IS, McLaughlin PJ: Naloxone modulates body and organ growth of rats: Dependency on the duration of opioid receptor blockade and stereospecificity. Pharmacol Biochem Behav 1989;33:325-328.
31. Hauser KF, McLaughlin PJ, Zagon IS: Endogenous opioid systems and the regulation of dendritic growth and spine formation. J Comp Neurol 1989;281:13-22.
32. Zagon IS, Hurst WJ, McLaughlin PJ: Transplacental transfer of naltrexone in rats. Life Sci 1997;61:1261-1267.
33. Zagon IS, Hurst WJ, McLaughlin PJ: Naltrexone is not detected in preweaning rats following transplacental exposure: Implications for growth modulation. Life Sci 1998;62:221-227.
34. Zagon IS, McLaughlin PJ: Perinatal methadone exposure and brain development: A biochemical study. J Neurochem 1978;31:49-54.
35. Zamenhof S, Bursztyn H, Rich K, Zamenhof P: The determination of deoxyribonucleic acid and of cell number in brain. J Neurochem 1964;11:505-509.
36. Zagon IS, Tobias SW, Hytrek SD, McLaughlin PJ: Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters μ opioid receptors. Pharmacol Biochem Behav 1998;59:201-207.
37. Moussavi R, Meisami E, Timiras PS: Compensatory cell proliferation and growth in the rat heart after postnatal hypothyroidism. Am J Physiol 1985;248:E381-E387.
38. Slotkin TA, Seidler FJ, Kavlock RJ, Bartolome JV: Fetal dexamethasone exposure impairs cellular development in neonatal rat heart and kidney: Effects on DNA and protein in whole tissues. Teratology 1991;43:301-306.
39. Zagon IS, Roesener CD, Verderame MF, Ohlsson-Wilhelm BM, Levin RJ, McLaughlin PJ: Opioid growth factor regulates the cell cycle of human neoplasias. Int J Oncol 2000;17:1053-1061.
40. McLaughlin PJ, Wu Y: Identification and characterization of the ζ-opioid receptor in developing rat heart. Am J Physiol 1998;272:R1841-R1846.
41. Clubb FJ, Bishop SP: Formation of binucleated myocardial cells in the neonatal rat. Lab Invest 1984;50:571-577.
42. Rumyantsev PP: Interrelationships of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977;51:187-273.
43. Zak R: Cell proliferation during cardiac growth. Am J Cardiol 1973;31:211-219.
44. Botto LD, Correa A, Erickson JD: Racial and temporal variations in the prevalence of heart defects. Pediatrics 2001;107:E32.
45. Rosenthal GR: Prevalence of congenital heart disease; in Garson A, Bricker JT, Fisher DJ, Neish SR (ed): Science and Practice of Pediatric Cardiology, Ed 2. Baltimore, Williams & Wilkins, 1998, chapter 48, pp 1083-1105.
46. Argao EA, Kern MJ, Branford WW, Scott WJ, Potter SS: Malformations of the heart, kidney, palate, and skeleton in α-MHC-Hoxb-7 transgenic mice. Mech Dev 1995;52:291-303.
47. Fuller RK, Hiller-Sturmhofel S: Alcoholism treatment in the United States: An overview. Alcohol Res Health 1999;23:69-77.